BRAF and thyroid tumor: In detail, we analyzed 6 thyroid tumors and 2 lymph node metastases from mice characterized by thyroid doxycycline (dox)-inducible BRAFV600E expression in a p53-/- background (TetOn-BRAF-P53), treated for 6–10 weeks with dox to induce BRAFV600E expression.